Teacher Retirement System of Texas Purchases 557,348 Shares of Certara, Inc. (NASDAQ:CERT)

Teacher Retirement System of Texas increased its position in shares of Certara, Inc. (NASDAQ:CERT) by 13.9% in the 4th quarter, HoldingsChannel reports. The firm owned 4,557,951 shares of the company’s stock after acquiring an additional 557,348 shares during the quarter. Teacher Retirement System of Texas’ holdings in Certara were worth $48,542,000 at the end of the most recent reporting period.

Several other institutional investors and hedge funds have also bought and sold shares of CERT. Venturi Wealth Management LLC raised its stake in Certara by 839.1% during the fourth quarter. Venturi Wealth Management LLC now owns 2,808 shares of the company’s stock worth $30,000 after acquiring an additional 2,509 shares in the last quarter. Blue Trust Inc. raised its stake in Certara by 20.9% during the fourth quarter. Blue Trust Inc. now owns 4,747 shares of the company’s stock worth $56,000 after acquiring an additional 822 shares in the last quarter. KBC Group NV raised its stake in Certara by 48.2% during the third quarter. KBC Group NV now owns 4,873 shares of the company’s stock worth $57,000 after acquiring an additional 1,584 shares in the last quarter. ANTIPODES PARTNERS Ltd raised its stake in Certara by 204.7% during the fourth quarter. ANTIPODES PARTNERS Ltd now owns 5,442 shares of the company’s stock worth $58,000 after acquiring an additional 3,656 shares in the last quarter. Finally, GAMMA Investing LLC raised its stake in Certara by 442.2% during the fourth quarter. GAMMA Investing LLC now owns 8,421 shares of the company’s stock worth $90,000 after acquiring an additional 6,868 shares in the last quarter. Institutional investors own 73.96% of the company’s stock.

Wall Street Analysts Forecast Growth

CERT has been the subject of several research analyst reports. William Blair reissued a “market perform” rating on shares of Certara in a research note on Thursday, February 27th. Stephens reissued an “overweight” rating and set a $17.00 target price on shares of Certara in a research note on Thursday, February 27th. TD Cowen assumed coverage on Certara in a research note on Thursday, February 27th. They issued a “buy” rating and a $16.00 price objective for the company. Finally, Barclays upped their price objective on Certara from $12.00 to $13.00 and gave the company an “equal weight” rating in a research note on Friday, February 28th. Four investment analysts have rated the stock with a hold rating and four have given a buy rating to the company’s stock. According to MarketBeat, the stock has an average rating of “Moderate Buy” and a consensus target price of $15.83.

Certara Stock Performance

Certara stock opened at $10.60 on Friday. The company has a market capitalization of $1.71 billion, a P/E ratio of -53.00, a P/E/G ratio of 9.29 and a beta of 1.60. The business has a 50 day moving average of $12.55 and a 200-day moving average of $11.50. The company has a debt-to-equity ratio of 0.28, a current ratio of 2.86 and a quick ratio of 2.86. Certara, Inc. has a 1 year low of $9.41 and a 1 year high of $19.18.

About Certara

Certara, Inc, together with its subsidiaries, provides software products and technology-enabled services to customers for biosimulation in drug discovery, preclinical and clinical research, regulatory submissions, and market access in the United States and internationally. It offers solutions for model-informed drug development, as well as biosimulation solution used to predict both pharmacokinetics and pharmacodynamics.